Diclofenac Sodium/Triclocarban

双氯芬酸钠/三氯卡班

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDiclofenac Sodium/Triclocarban
Drug Alias Name双氯芬酸钠+三氯卡班Diclofenac Sodium+Triclocarban双氯芬酸钠-三氯卡班Diclofenac Sodium-TriclocarbanDiclofenac Sodium●Triclocarban +[11] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Diclofenac Sodium
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSphaera Pharma
China Registration ClassN/A

Develop Information

Active CompaniesSphaera Pharma
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A